Arvinas

ARVN · NASDAQ

$7.66+$0.40 (+5.51%)TodayMarket closed ·
Prev close $7.26

Who owns ARVN

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 46.7% of ARVN’s shares.

  • BlackRock Institutional Trust Company, N.A.8.6%
  • Vanguard Portfolio Management, LLC6.4%
  • D. E. Shaw & Co., L.P.5.4%
  • Pfizer Inc.5.4%
  • Next 6 largest institutions21.0%
  • All other shareholders53.3%
Top institutional holders of ARVN
HolderShares% of shares
BlackRock Institutional Trust Company, N.A.5.55M8.59%
Vanguard Portfolio Management, LLC4.12M6.39%
D. E. Shaw & Co., L.P.3.50M5.42%
Pfizer Inc.3.46M5.36%
Armistice Capital LLC2.80M4.33%
Vanguard Capital Management, LLC2.71M4.21%
Two Sigma Investments, LP2.57M3.99%
State Street Investment Management (US)2.20M3.40%
Geode Capital Management, L.L.C.1.67M2.58%
Qube Research & Technologies Ltd1.59M2.47%

Largest mutual fund holders

Top mutual fund holders of ARVN
HolderShares% of shares
Vanguard Total Stock Market Index Fund1.92M2.98%
Vanguard Strategic Equity Fund1.71M2.65%
iShares Russell 2000 ETF1.54M2.39%
Vanguard Explorer Fund896.37K1.39%
State Street SPDR S&P Pharmaceuticals ETF840.36K1.30%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $518.08K (8 trades) of ARVN on the open market, with no buys.

Latest ARVN insider transactions
InsiderTypeSharesValue
Kennedy Edward Moore Jr.Award22.71K—
Kennedy Edward Moore Jr.Award15.53K—
Morrison BriggsAward22.71K—
Morrison BriggsAward15.53K—
Smaldone Alsup LaurieAward22.71K—
Smaldone Alsup LaurieAward15.53K—
Bain LindaAward22.71K—
Bain LindaAward15.53K—
Cunningham EverettAward22.71K—
Cunningham EverettAward15.53K—

Short interest

Settled Sep 30, 2026

Shares short
5.39M
Days to cover
6.58
% of shares outstanding
8.35%
Average daily volume
819.22K
Change since last report
+8.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.